Clinical Roundup Drug shows promise in overcoming endocrine therapy resistance in breast cancer November 18, 2022Vol.48 No.42
Clinical Roundup NYU study shows cancer cell biology may predict response to immunotherapy November 18, 2022Vol.48 No.42
Drugs & Targets FDA grants accelerated approval to Elahere for platinum-resistant ovarian cancer November 18, 2022Vol.48 No.42
Drugs & Targets Lynparza receives positive CHMP opinion for metastatic, castration-resistant prostate cancer November 18, 2022Vol.48 No.42
Drugs & Targets Fox Chase, Oryzon Genomics collaborate on Iadademstat clinical trial November 18, 2022Vol.48 No.42
Drugs & Targets MD Anderson, Exscientia collaborate to develop oncology treatments using AI November 18, 2022Vol.48 No.42
In Brief Gregory Reaman named scientific director of NCI’s Childhood Cancer Data Initiative November 11, 2022Vol.48 No.41
In Brief Fox Chase, Sylvester collaborate with Pfizer to identify genetic drivers of cancer disparities November 11, 2022Vol.48 No.41
In Brief UPMC, St. Catherine Specialty Hospital to expand cancer care in Croatia November 11, 2022Vol.48 No.41
